Publications by authors named "K Sumathi Nitin"

Pentoxifylline (PTX) is a widely used pharmacological agent for the selection of motile sperm in both normozoospermic and asthenozoospermic ejaculates prior to their use in assisted reproductive technologies (ARTs), e.g. intracytoplasmic sperm injection (ICSI).

View Article and Find Full Text PDF
Article Synopsis
  • Fertility is influenced by various sperm functions, with poor motility being a leading cause of male infertility due to its dependence on cAMP signaling which is broken down by phosphodiesterases (PDEs).
  • PDE inhibitors, like pentoxifylline (PTX), are used to enhance sperm motility in assisted reproduction technologies, but they can have negative side effects, such as causing premature acrosome reactions.
  • The study reveals that theophylline (TP) binds to the same site as PTX with greater affinity, suggesting potential for TP as a fertility treatment, although its inhibitory mechanism remains unknown.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the Pictet-Spengler reaction catalyzed by strictosidine synthases (STR), examining how various substrates, including tryptamine, interact with STRs from two plant sources.
  • Using isothermal titration calorimetry, the research identified different binding properties such as order and cooperativity, finding that OpSTR shows stronger cooperative binding than RsSTR.
  • Additionally, crystallographic studies and molecular dynamics simulations were employed to explore substrate interactions and the effects of pH, with implications for drug design and enzyme engineering.
View Article and Find Full Text PDF

Background: Cotadutide is a dual glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptor agonist peptide. The objective of this analysis was to develop a population pharmacokinetic (popPK) model of cotadutide, and to identify any potential effect on the PK from intrinsic and extrinsic covariates.

Methods: The popPK analysis utilized a non-linear mixed-effects modeling approach using the data from 10 clinical studies in different participant categories following once-daily subcutaneous dose administration ranging from 20 to 600 μg.

View Article and Find Full Text PDF